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REVIEW ARTICLES
Surgeons for centuries have salvaged patients 
dying with abdominal catastrophes, ranging from 
simple appendicitis to advanced peritonitis. Sur-
vival dominated former surgical goals, but with ad-
vances in resuscitations, sepsis source control, and 
surgical techniques, there is now more time to focus 
on quality outcomes with reduction in morbidity, 
re-admission, and reoperation [1, 2]. Bundles have 
been used to improve perioperative care and have 
been highly effective in reducing surgical site infec-
tion (SSI), including deep organ space infection [3]. 
In conjunction with clinical improvements, pow-
erful data registries are alerting us to the frequency 
and problems posed by incisional hernia [4]. Over 
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one million laparotomies are performed annually 
in the USA alone. Increasing use of metrics allows 
more transparent identification of both early and 
late complications. Surgical site occurrence (SSO) 
occurs on average in 15% of those undergoing lap-
arotomy (range 5–45%), with significant cost and 
morbidity [5]. 
There have been many paradigm shifts in her-
nia prevention and repair since Usher’s first use of 
Marlex to repair an incisional hernia (IH) in 1958 [6]. 
In general it is now standard of care to use mesh 
in both umbilical and incisional hernia repair [7]. 
This is not entirely uniform, however, and the use of 
mesh for umbilical hernia repair is debated, possibly 
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Abstract 
Background: Incisional hernia (IH) occurs in approximately 25% of laparotomies. Prophy-
lactic mesh placement (PMP) may significantly reduce IH but is not widely used. This 
paper will review the evidence relating to the role of PMP in laparotomy and its ability 
to effectively and safely have an impact on hernia reduction.
Methods: An ethically approved review of all published English articles relating to IH 
prevention following laparotomy was undertaken at Letterkenny University Hospital by 
searching PubMed, Scopus, and electronic databases over a 20-year period from January 
1999 to March 2019. The search terms “incisional hernia”, “laparotomy”, “mesh placement”, 
“reoperation”, “readmitted”, and “rates” were used in combination.
Results: The literature identified 17 publications, of which 14 were randomised, con-
trolled trials and three were prospective cohort studies from 22 countries. Bariatric sur-
gery accounted for eight of the 17 studies. Onlay mesh placement was used in five 
studies. Preperitoneal, retrorectus, intra-peritoneal, combinations of and sublay were 
used in 4, 3, 2, 2, and 1 studies, respectively. In two studies both sublay and onlay were 
performed. A total of 2777 patients were reported. One study had two publications with 
different lengths of follow-up.
Conclusions: Currently surgeons need to consider changing practice to firstly ensure 
they practice optimum laparotomy closure technique and potentially use PMP. If not 
using PMP they need to question why, because PMP will more than halve the IH rate, 
especially in higher risk patients undergoing laparotomy.
Key words: incisional hernia, laparotomy, emergency surgery, prophylactic mesh 
placement, mesh. 
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related to the concern that mesh may increase the 
risk of surgical site infections [8]. 
Surgeons have been slow to recognise the bur-
den of incisional hernia following laparotomy [9, 10]. 
The incidence of incisional hernias is approximate-
ly 15% at one year, rising to 25% at three years 
(range 10–50%) [11]. Prophylactic mesh placement 
(PMP) has been shown to at least halve the problem 
[12, 13]. 
Mesh has been placed in wounds for centuries 
with variable results [14]. The concept of mesh in-
sertion and potential mesh related complications 
has been a barrier to their insertion. Contaminated 
wounds during index laparotomy or subsequent SSI 
development are a source of great anxiety to sur-
geons [15]. 
PMP involves mesh implantation, usually in the 
onlay or underlay position. Underlay can either be 
in retrorectus positions, preperitoneal or intraperito-
neally (IPOM) at the time of initial abdominal fascial 
closure. Recent studies suggest that prevention of 
IH via PMP may be the solution to this hernia epi-
demic [16, 17]. 
This paper will review the evidence relating to 
the role of prophylactic mesh placement at laparot-
omy and its ability to effectively and safely impact 
on hernia reduction.
METHODS
An ethically approved review of all published 
English articles relating to IH prevention following 
laparotomy was undertaken at Letterkenny Univer-
sity Hospital searching PubMed, Scopus, and elec-
tronic databases over a 20-year period from Janu-
ary 1999 to March 2019. The search terms “incisional 
hernia”, “laparotomy”, “mesh placement”, “reopera-
tion”, “readmitted” and “rates” were used in combi-
nation with Boolean operators AND or OR. Studies 
were included in this review if they were either ran-
domized controlled trials (RCTs) or prospective co-
hort studies involving analysis of incisional hernia, 
following use of mesh prophylactically placed either 
in laparotomy or open abdomen closure. Studies re-
lating to stomal herniation, paediatric, and those in 
which data was inadequate for interpretation were 
not included.
Incisional hernia was clinically defined as any vis-
ible and/or palpable ‘‘blowout’’ within a distance of 
3 cm from the midline abdominal scar and an ex-
ample is shown in Figure 1. The ultrasonic criteria 
of incisional hernia were a visible gap within the ab-
dominal wall and/or ‘‘tissue moving through the ab-
dominal wall by Valsalva manoeuvre’’ and/or a detect-
able ‘‘blowout’’. For the diagnosis of incisional hernia, 
either clinical criteria, or ultrasound or CT criteria or 
both had to be fulfilled. The study did not distinguish 
between single and multiple incisional hernias.
RESULTS 
The literature identified 17 publications, of 
which 14 were RCTs and 3 prospective cohort stud-
ies from 22 countries. Bariatric surgery accounted 
for 8 of the 17 studies. Onlay mesh placement was 
used in 5 studies. Preperitoneal, retrorectus, intra-
peritoneal, combinations of and sublay were used 
in 4, 3, 2, 2 and 1 studies respectively. In two stud-
ies both sublay and onlay were performed (Table 1), 
a total of 2777 patients were reported. One study 
had two publications with different lengths of fol-
low up.
WHICH PATIENTS SHOULD BE TREATED?
Many issues come into play before answering 
this question; what is the patient’s physiology, oper-
ative wound classification, cost and type of mesh to 
be used. Before considering PMP we have to ensure 
appropriate decision making and surgical technique 
are optimized at the first operation. 
The choice of primary incision is important as 
it has been suggested that lateral paramedian inci-
sions have a lower incidence than with midline inci-
sions [18, 19]. Some studies have however failed to 
detect any difference [20, 21]. Paramedian incisions 
are more difficult to perform than midline incision. 
Muscle splitting incisions such as the Lanz, gridiron 
incision and the Pfannenstiel incision have a slightly 
lower rate of wound complications. These incisions 
however provide reduced access to the abdomen 
and increased numbness [22]. A number of key sur-
gical techniques proven to reduce incisional hernia 
without the use of mesh are shown in Table 2. These 
should be implemented as a routine.
Nearly all published trials have shown benefit 
when PMP is used in higher risk patient as shown 
in Table 3 [7, 23–25]. Patients undergoing midline 
laparotomies are at the greatest risk, with rates in 
general approaching 20% at 3 years although this 
FIGURE 1. A large lower abdominal incisional hernia one year post 
laparotomy
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is higher in select groups. Those undergoing aortic 
surgery are at increased risk [26].
Fischer et al. studied the incidence of incisional 
hernia post laparotomy and associated risk factors, 
enabling them to create a composite risk score [27]. 
In their cohort of 12,373 patients there was a wide 
variation in the incidence of IH from 0.5 to 20.6%, in 
the low and extreme risk groups, respectively. A sim-
ilar study by Basta et al. risk stratified patients fol-
lowing bariatric surgery and were able to accurately 
predict the risk [28]. Both studies report increased 
healthcare costs associated with their higher risk 
groups. The use of a risk stratification model would 
allow healthcare providers to be more targeted 
when considering the use of a prophylactic mesh. 
Goodenough and colleagues, in a prospective 
study using a scoring model to predict IH after ab-
dominal surgery, found three preoperative and in-
traoperative findings independently associated with 
IH formation [25]. These were surgical approach 
(open laparotomy vs. hand-assisted laparoscopy vs. 
laparoscopy), COPD, and BMI > 25 kg m-2. In their 
study the lowest risk patients developed an IH 
in 5.5% compared to over 50% in the highest risk 
group. While their score is straightforward to calcu-
late, practical, and can be estimated preoperatively 
to determine a patient’s risk it is not widely used.
Although the data are favourable and consistent 
for prophylactic mesh augmentation, the Guideline 
Development Group decided that larger trials are 
needed to make a strong recommendation to per-
form prophylactic mesh augmentation for all pa-
tients within certain risk groups [7]. 
We should not forget preoperative risk reduc-
tion strategies starting with appropriate patient 
selection, weight loss programs, nutritional optimi-
zation, cessation of smoking and pre-habilitation, to 
include pre-operative chest physio, are to be com-
mended. In the emergency situation, and in those 
undergoing major abdominal wall reconstructions, 
factors to reduce intra-abdominal pressure are im-
portant [29, 30]. 
TABLE 1. Randomized controlled trials and prospective studies of prophylactic mesh placement during laparotomy 
Study Year Location Patients Position Study No
Pans [33] 1998 Belgium Bariatric IPOM 288
Strzelczyk [32] 2002 Poland Bariatric Onlay 60
Gutierrez de la Pena [51] 2003 Spain Cancer Onlay 88
Strzelczyk [52] 2006 Poland Bariatric Retrorectus 72
El-Khadrawy [53] 2009 Egypt Bariatric Preperitoneal 40
Bevis [54] 2010 UK AAA Sublay 80
Llaguna [55] 2011 USA Bariatric Preperitoneal 106
Abo-Ryia [56] 2013 Egypt Bariatric Preperitoneal 64
Curro [57] 2012 Italy Bariatric Retrorectus 95
Caro-Tarrago [58] 2014 Spain Cancer Onlay 160
Sarr [59] 2014 USA Bariatric Preperitoneal 380
Bali [60] 2015 Greece AAA Onlay 40
Timmermans [36] 2015 Netherlands AAA Onlay-sublay 480
Muysoms [61] 2016 Belgium AAA Retrorectus 114
Jairam [13] 2017 Austria Germany Holland Mixed Onlay-sublay 480
Caro-Tarrago [62] 2019 Spain Cancer Onlay 80
Kohler [37] 2019 Switzerland Cancer IPOM 150
TABLE 2. Surgical technique as prevention of incisional hernia
Measuring wound length
Documenting the suture to wound length
Suture to wound length ratio 4 : 1
Use of self-locking sutures




TABLE 3. Patients at great risk of incisional hernia 
Obese, BMI > 27 kg m-2
Elderly 
Aortic or bariatric surgery
History of hernias 
Carcinoma
Chronic obstructive pulmonary disease
Emergency surgery
Previous laparotomy 
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WHAT TYPE OF MESH
The choice of mesh can be simplified into 3 main 
categories: synthetic, biosynthetic and biological. 
In addition the mesh may be absorbable or non-
absorbable, with or without a hybrid component. 
Furthermore meshes can vary in weight, pore size 
and resistant to colonization [31]. This classification 
can be further complicated by additive agents rang-
ing from biospheres to antiseptic impregnation. 
Prolene based meshes have been used since 2002 
when Strzelczyk found polyprolene mesh highly 
effective in preventing IH with 0% IH in the mesh 
group compared to 21% in the non mesh group at 
6 months follow-up [32]. Pans however, in one of 
the first studies almost 21 years ago, reported that 
absorbable PMP had no effect on reducing IH with 
22.9% IH rate in the mesh versus 28.5% in the no 
mesh group. Pan used intraperitoneal polyglactin 
mesh which was not fixed [33].
In a recent systematic review Muysoms suggest-
ed there is no overwhelming evidence on the effec-
tiveness of prophylactic non-permanent absorb-
able biological or biosynthetic mesh for the closure 
of laparotomies. There is no evidence that, in this 
setting, a non-permanent absorbable biological or 
biosynthetic mesh would be preferred to synthetic 
non-absorbable mesh, both in clean or clean-con-
taminated surgery [34]. Furthermore, the on-going 
PREBIOUS trial is attempting to determine the ef-
ficacy of bioabsorbable meshes [35]. The potential 
attraction of bioabsorbable meshes is that they be-
have like synthetics with good tensile strength but 
eventually reabsorb which could lead to less chronic 
pain and a possible decreased infection risk. There 
is increasing interest in hybrid meshes but no real 
data to support their use. 
WHICH POSITION SHOULD THE MESH BE PLACED?
Mesh can be placed either as an onlay, retro-
rectus, sublay in the preperitoneal plane or intra-
peritoneally (IPOM). An example of an onlay mesh 
placement is shown in Figure 2. Potentially a combi-
nation of locations could be used. 
Kohler in a recent randomized trial found prophy-
lactic intraperitoneal mesh implantation significantly 
reduced the incidence of incisional hernia 3 years af-
ter laparotomy compared with standard abdominal 
closure in a high-risk population with IH occurring in 
7.2% vs. 18.5% in the non-mesh group [37]. At pres-
ent there is little evidence on the long-term results 
of the prophylactic use of mesh, but the protective 
effect of the use of an onlay mesh in abdominal wall 
closure is maintained for at least up to 5 years after 
surgery. 
Jairam et al. in the PRIMA trial, a randomised 
controlled trial from 3 countries, found onlay mesh 
reinforcement significantly reduced the incidence 
of incisional hernia after midline laparotomy in pa-
tients at high risk for incisional hernia (i.e. those with 
abdominal aortic aneurysm or a BMI ≥ 27 kg m-²). 
Sublay mesh reinforcement did not have a sig-
nificant effect on the incidence of incisional hernia 
compared with primary suture [13]. 
WHAT ABOUT IN CONTAMINATION?
To-date there have been several studies dem-
onstrating the efficacy of using macroporous poly-
propylene mesh in both class 2 and class 3 wounds 
[38, 39]. 
There is a growing body of literature on the ef-
ficacy of bioabsorbable meshes for a similar pur-
pose as well as on-going clinical studies such as the 
PREBIOUS trial [35, 40]. While Choi et al. in a study of 
the adverse effect of mesh in clean and clean contam-
inated ventral hernia repair expressed caution about 
its use; their study is somewhat dated and without 
information on the type of mesh or the primary 
surgery [41]. They found postoperative occurrences 
were significantly greater in clean-contaminated and 
contaminated cases using mesh when compared 
with clean cases, with odds ratios of 3.56 (3.25–3.89) 
and 5.05 (1.78–12.41) respectively. There was a sig-
nificantly increased risk of superficial SSI (2.53), deep 
SSI (3.09) and organ/space SSI (6.16), wound disrup-
tion (4.41), pneumonia (4.43), and sepsis (4.90) for 
clean-contaminated cases where mesh was used. 
Argudo et al. in a retrospective study found that 
the use of a partially absorbable, lightweight large 
pore prophylactic mesh in the closure of emergency 
midline laparotomies is feasible for the prevention of 
incisional hernia without adding a substantial rate of 
morbidity to the procedure, even if high contamina-
tion or infections are present suggesting that acel-
FIGURE 2. Prophylactic TIGR onlay mesh fixed by tacking on right 
side and suturing on left
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lular dermal matrix may be an acceptable option for 
repair of clean contaminated or contaminated de-
fects, with a 23% 2-year rate of hernia recurrence in 
reinforced acellular dermal matrix repairs [42]. 
Itani et al.’s prospective, multicenter, single-arm 
study of open VIH repairs of contaminated abdomi-
nal defects with a non-cross-linked, porcine, acellu-
lar dermal matrix found an early recurrence rate of 
7.1% in clean-contaminated defects at approximate-
ly 11 months’ follow-up. They found no unanticipat-
ed adverse events occurred, and no tissue matrix 
required complete excision. There were however 
22 hernia (28%) recurrences by month 24. There was 
no correlation between infection-related events and 
hernia recurrence [43]. In other areas such as emer-
gency stoma creation Lykke et al. found that the in-
sertion of absorbable mesh, even in the presence of 
contamination, was not associated with increased 
complications [44]. It appears that permanent syn-
thetic or biosynthetic mesh can now be used in 
clean-contaminated and contaminated fields.
WHAT ABOUT THE OPEN ABDOMEN CLOSURE?
There is increasing evidence that final closure of 
the open abdomen will benefit by PMP. The evidence 
however is still limited and this would depend on the 
degree of contamination. When placement of mesh is 
considered reasonably safe it should be macro porous. 
Studies have shown that VAC-IPOM in patients 
with OA treatments decrease re-operations, duration 
of hospital and ICU stay, and the incidence of inci-
sional hernia, when compared with VAWCM, which 
represents the current standard of care [45, 46].
COSTS 
According to recent estimates healthcare costs 
related to incisional hernias vary from $3,875 to 
$98,424 per patient and the overall cost approaches 
3 billion dollars in the USA alone [47]. More than 
340,000 ventral hernia surgical procedures are per-
formed in the United States each year, accounting 
for at least $3.2 billion in health care. It has been cal-
culated that in the United States, each 1% reduction 
in hernia recurrence would result in a saving of at 
least $32 million in procedural costs. The use of mesh 
could reduce the incidence of IH from 25–30% to 
10% and therefore is cost-effective due to the num-
ber needed to treat obtained: one IH was prevented 
for every 5 prophylactic meshes that were used.
The mean total cost for an IH in France in 2011 
was estimated to be 6451€, ranging from 4731€ 
for unemployed patients to 10,107€ for employed 
patients whose indirect costs (5376€) were slightly 
higher than the direct costs. Reducing the inci-
dence of IH after abdominal surgery by 5% follow-
ing implementation of the European Hernia Society 
Guidelines on closure of abdominal wall incisions, or 
maybe even by use of prophylactic mesh augmen-
tation in high risk patients would result in a national 
cost savings of 4 million euros [7].
PROBLEMS WITH MESH INSERTION
Mesh infection, explantation, migration and fis-
tulation are uncommon. Seroma rates are slightly 
increased with onlay and increased pain may be 
seen especially in the early post-operative period 
with the retrorectus approach. When an SSI occurs 
in the presence of mesh it may take longer to heal.
During analysis significantly (P = 0.002) more 
seromas were detected after OMA (n = 34, 18.1%) 
compared with primary suture (n = 5, 4.7%) and 
sublay mesh augmentation (n = 13, 7.0%). No dif-
ferences were seen in surgical site infection, hema-
toma, reintervention, or readmission [35]. 
At 6 weeks, significantly more patients in the 
mesh group reported postoperative pain com-
pared with patients in the control group (34 of 
52 [65.4%] vs. 26 of 59 [44.1%]; effect size, 21.3%; 
95% CI: 4–41%; P = 0.04). Pain intensity was higher 
in the mesh group compared with the control group 
at 6 weeks (mean VAS score, 1.61 vs. 0.83; VAS score 
difference, 0.78; 95% CI: 0.10–1.46%; P = 0.02). 
At 1 and 3 years after surgery, no difference in pain 
perception was observed between the groups). No 
difference in surgical site infections was observed, 
but time to complete wound healing of surgical site 
infection was significantly longer in patients with 
mesh implantation (median [interquartile range], 
8 [6–24] weeks compared with 5 [1–9] weeks; P = 0.03). 
Trunk extension was significantly decreased after 
mesh implantation compared with the control group. 
A trend towards increased chronic pain after mesh 
implantation has been reported in the past [37]. 
CURRENT LIMITATIONS
There is no gold standard for the diagnosis of 
ventral hernias. Clinical examination is potentially 
subject to under diagnosis, can vary widely between 
clinicians, and is affected by patient factors such as 
obesity. Radiographic imaging has been shown 
to have significant inter-observer variability. Even 
patient-reported results are inaccurate, with up to 
one-third of patients unaware that they have a VIH. 
It remains to be seen whether in fact patients with 
incisional hernia are best observed or subjected to 
surgery, and this will be answered by the AWARE 
study [48]. The providers of surgical and critical 
care have all seen the sequelae of strangulated in-
cisional hernia and realise that we need to re-think 
our approach. We may have overlooked some basic 
anatomical factors relating to the linea alba. Mosch-
cowitz in 1914 identified the vascular lacunae theory 
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FIGURE 3. New incisional hernia below site of previous prophylac-
tic mesh placement in a patient with multiple previous lower mid-
line incisions
with perforation of the linea in significant numbers 
[49]. Sugrue described the concept of the fenestrat-
ed linea alba. In a prospective study of 146 patients, 
74% male, mean body mass 84 ± 16 kg, mean age 
48.6 ± 12.0 years, were studied. Ninety-four (64%) 
had a single defect, mean size 17.5 ± 8.3 mm (range 
3–44 mm). Thirty-three (22%) patients had two de-
fects, the mean size of the second defect 13.1 mm 
(range 1–22 mm) at a mean distance of 5.7 mm 
(range 1–30 mm). Fifteen (10%) had three defects, 
the mean size of the third defect 11 mm (range 
1–20 mm) at a mean distance of 5.7 mm (range 
1–30 mm). Four (3%) patients had four defects. All 
defects were cephalad. The linea alba should be ex-
posed for 3 cm in a cephalad direction at umbilical 
hernia repair to identify and fix these defects. It may 
be one of the reasons that PMP reduces IH rates [50].
As can be seen in Figure 3 incisional hernia may 
develop down the whole length of a previous in-
cision. In Kohler’s recent publication there was in-
creased early postoperative pain and prolonged 
wound healing of surgical site infection in those 
having mesh. While the pain difference in those who 
received mesh was confined to the early post-oper-
ative period long term trunk extension was reduced 
in those receiving a mesh [37]. 
CONCLUSIONS
This original review has identified significant evi-
dence to support PMP in terms of both the short and 
long term benefit with halving the incisional hernia 
rate. Both permanent and biosynthetic offer different 
profiles and further prospective RCTs will help iden-
tify the most appropriate locations and type of mesh 
placement. Currently surgeons need to consider why 
they are not going to place a prophylactic mesh in 
a higher risk patient at laparotomy.
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